《新股消息》百心安(02185.HK)公开发售轻微超购及下限定价21.25元一手中签率85%_老虎社区_美港股上老虎

《新股消息》百心安(02185.HK)公开发售轻微超购及下限定价21.25元一手中签率85%

AAFN2021-12-22

百心安(02185.HK)公布招股结果，每股发售价定为21.25元，为下限定价(招股价介乎每股21.25至24.79元)，香港公开发售部分仅录得超额认购约0.52倍。而国际发售部分亦轻微超购。每手500股计，一手中签率85%，认购2手即1,000股可稳获一手。该股将於明日(23日)挂牌。独家保荐人为华泰国际。公司预料，上市净集资约4.42亿元，当中约62%用於正在进行的确认性临床试验、注册备案的筹备事宜以及核心产品Bioheart的计划中商业化上市；约21.3%用於在中国正在进行的随机对照临床试验以及肾神经阻断在研产品第二代Iberis的持续开发；约6.7%用於管线中其他在研产品的研发、进行中临床前研究及已规划的临床试验；余下10%作一般企业及营运资金用途。(na/s)~阿思达克财经新闻网址: www.aastocks.com

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

.
·2021-12-22
好
回复
1
举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2193161743?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","is_english":false,"pubTime":"2021-12-22 08:24","share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","id":"2193161743","market":"us","top_or_hot":-1,"title":"《新股消息》百心安(02185.HK)公开发售轻微超购及下限定价21.25元  一手中签率85%","media":"AAFN","content":"<html><body><p>百心安(02185.HK)公布招股结果，每股发售价定为21.25元，为下限定价(招股价介乎每股21.25至24.79元)，香港公开发售部分仅录得超额认购约0.52倍。而国际发售部分亦轻微超购。每手500股计，一手中签率85%，认购2手即1,000股可稳获一手。该股将於明日(23日)挂牌。独家保荐人为华泰国际。公司预料，上市净集资约4.42亿元，当中约62%用於正在进行的确认性临床试验、注册备案的筹备事宜以及核心产品Bioheart的计划中商业化上市；约21.3%用於在中国正在进行的随机对照临床试验以及肾神经阻断在研产品第二代Iberis的持续开发；约6.7%用於管线中其他在研产品的研发、进行中临床前研究及已规划的临床试验；余下10%作一般企业及营运资金用途。(na/s)~阿思达克财经新闻网址: www.aastocks.com</p></body></html>","source":"aastocks","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《新股消息》百心安(02185.HK)公开发售轻微超购及下限定价21.25元  一手中签率85%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《新股消息》百心安(02185.HK)公开发售轻微超购及下限定价21.25元  一手中签率85%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:24 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1151123&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>百心安(02185.HK)公布招股结果，每股发售价定为21.25元，为下限定价(招股价介乎每股21.25至24.79元)，香港公开发售部分仅录得超额认购约0.52倍。而国际发售部分亦轻微超购。每手500股计，一手中签率85%，认购2手即1,000股可稳获一手。该股将於明日(23日)挂牌。独家保荐人为华泰国际。公司预料，上市净集资约4.42亿元，当中约62%用於正在进行的确认性临床试验、注册备案的...</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1151123&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00388","symbol_name":"香港交易所","start_time":0,"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1151123&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","article_id":"2193161743","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2193161743","pubTimestamp":1640132660,"columns":[{"name":"新股","id":7,"label_key":null}],"sourceInfo":{"source_id":"aastocks","name":"阿思达克财经"},"weMediaInfo":null,"summary":"百心安公布招股结果，每股发售价定为21.25元，为下限定价，香港公开发售部分仅录得超额认购约0.52倍。而国际发售部分亦轻微超购。每手500股计，一手中签率85%，认购2手即1,000股可稳获一手。该股将於明日挂牌。","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"00388":"香港交易所","02185":"百心安-B"},"translate_title":"[New share news] Baixin'an (02185. HK) has a slight overpurchase and a lower price of 21.25 yuan. The first-hand winning rate is 85%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00388":0.6,"02185":1},"content_text":"百心安(02185.HK)公布招股结果，每股发售价定为21.25元，为下限定价(招股价介乎每股21.25至24.79元)，香港公开发售部分仅录得超额认购约0.52倍。而国际发售部分亦轻微超购。每手500股计，一手中签率85%，认购2手即1,000股可稳获一手。该股将於明日(23日)挂牌。独家保荐人为华泰国际。公司预料，上市净集资约4.42亿元，当中约62%用於正在进行的确认性临床试验、注册备案的筹备事宜以及核心产品Bioheart的计划中商业化上市；约21.3%用於在中国正在进行的随机对照临床试验以及肾神经阻断在研产品第二代Iberis的持续开发；约6.7%用於管线中其他在研产品的研发、进行中临床前研究及已规划的临床试验；余下10%作一般企业及营运资金用途。(na/s)~阿思达克财经新闻网址: www.aastocks.com","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":691310939,"gmtCreate":1640135685119,"gmtModify":1640135685184,"author":{"id":"3586582918895260","authorId":"3586582918895260","name":" . ","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":0,"crmLevel":0,"crmLevelSwitch":0,"authorIdStr":"3586582918895260","idStr":"3586582918895260"},"htmlText":"好","listText":"好","text":"好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691310939","repostId":2193161743,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}